Ozon Pharmaceuticals has committed to a significant investment in the industrial and logistics sectors of the region by signing a “musataha agreement” to develop a new manufacturing facility in Dubai Industrial City. The new building will be 150,700 square feet in size, require an expenditure of over AED 293 million, and be fully operational by the following year.
Ceremony and Key Attendees
The agreement was formalized at an official ceremony during INNOPROM 2024 in Ekaterinburg. Attendees included Dr. Thani bin Ahmed Al Zeyoudi, Minister of State for Foreign Trade; Omar Al Suwaidi, Undersecretary of the Ministry of Industry and Advanced Technology; and Alexey Gruzdev, Deputy Minister of Industry and Trade of the Russian Federation. The signing was conducted by Saud Abu Alshawareb, Executive Vice President of Industrial at TECOM Group, and Dr. Mustafa Khalaf, General Manager of OZON Pharmaceuticals.
Strategic Importance and Local Impact
Saud Abu Alshawareb noted that localizing medical manufacturing boosts the ability to enhance supply chains, improve response times, and achieve self-sufficiency—all crucial for building resilience in the healthcare sector. This new facility aligns with the UAE’s strategic objectives, including Operation 300bn, the Make in the Emirates initiative, and the Dubai Economic Agenda ‘D33’.
Dr. Mustafa Khalaf emphasized OZON Pharmaceuticals’ commitment to impacting the manufacturing and healthcare sectors across the UAE, Middle East, and CIS regions. The new facility will ensure a steady supply of high-quality medicines, advance technological innovation, and elevate healthcare delivery standards.
Project Phases and Capacity
There will be two stages to the project. The first phase, estimated to cost AED 110 million, aims to increase the capacity of production to more than 300 million tablets annually. Key GCC markets as well as the regional markets in Iraq, Morocco, Algeria, and Libya were taken into consideration during the design of this facility.
Employment and technological features
The facility will hire 100 experts in the domains of production, pharmaceutical control, and quality assurance during the initial phase of operation. Additionally, end-to-end traceability and security are made possible by sophisticated medication tracking systems at every stage of the product creation cycle.
Role of Dubai Industrial City: Industry Presence
Dubai Industrial City stands as a key industrial and logistics hub in the region, hosting over 1,000 local, regional, and international companies. Notable tenants include Standard Carpets, Himalaya Wellness, IFFCO Group, and Unilever, along with more than 300 operational factories. With the addition of OZON Pharmaceuticals, the city further solidifies its position as a strategic center for industrial and medical manufacturing in the region.
The launch of OZON Pharmaceuticals’ new facility in Dubai Industrial City represents a significant advancement in transforming the local industrial and healthcare sectors. This AED293 million investment will boost local production capabilities and support the UAE’s broader goals of economic diversification and resilience. As the facility progresses through its development phases, it is expected to become a key hub for meeting the increasing healthcare needs of GCC countries and beyond.
